Bendazac L-lysine T3141
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Bendazac L-Lysine is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
CAS nr:
81919-14-4
Purity:
98%
Molecular Weight:
428,48
SMILES:
O(c1nn(c2c1cccc2)Cc1ccccc1)CC(=O)O.OC(=O)[C@@H](N)CCCCN
Formula:
C22H28N4O5
Pathway:
Others
Target:
Others
